| |
NEWLY AVAILABLE, NEWLY APPROVED
Off-the-Shelf
Knee Brace
The EBI" Alliance™ Off-the-Shelf Functional Knee Brace is now available.
The manufacturer notes that this brace will contour to anatomy (because of a
proprietary carbon fiber blend) and provide functional stability (by resisting
anterior translation of the tibia relative to the femur).
Functional stability features are said to include supracondylar pads placed in
the thigh's natural recess (to maintain brace position and overcome the leg's
cone shape), a femoral cuff superior portion shaped to fit the thigh's natural
curves, and a well-designed brace—thigh lateral-line fit (for maintaining
fit
during fluctuations of edema or atrophy).
In addition, according to EBI, the tibial cuff is shaped to provide close contact with the tibia’s bony prominences; the tibial keel is set flush along the tibia’s flat medial face to better control translation and rotation; the hinge’s 4-bar linkage system works with the knee’s natural motion; and clip-in stops provide different amounts (0°, 10°, 20°, 30°, 40°) of easily read range-of-motion control (these stops snap into place; no tools required).
The brace is available in more than 18 custom colors.
For more information, contact
EBI, LP
100 Interpace Parkway
Parsippany, NJ 07054-1079
Phone 800-526-2579
www.
ebimedical_support@ebimed.com
|
Women’s Total Knee Replacement
The Zimmer“ Gender Solutions™ High-Flex Knee, “designed to fit a woman’s anatomy,” will become widely available in the United States beginning in the fall
of 2006.
According to the manufacturer, 3-dimensional computed tomography was used in designing this knee replacement to accommodate 3 aspects of women’s knee anatomy. Compared with a man’s knee, a woman’s knee is narrower from side to side and more trapezoid in shape; the bone in the front is thinner; and the knee has a different tracking angle. The device maker indicates that the goals of the gender-specific design are to increase women’s relief from knee pain and restore more of their mobility and to raise women’s comfort and satisfaction with knee replacement surgery.
This device, which "will be implanted using existing, clinically successful surgical techniques, including Zimmer’s minimally invasive approaches," is said to accommodate up to 155° of flexion.
For more information, contact
Zimmer, Inc.
PO Box 708
Warsaw, IN 46581-0708
Phone 574-267-6131
www.zimmer.com
|
Patient-activated Transdermal
Analgesic System for Postoperative Pain
| The US Food and Drug Administration has approved IONSYS™ (fentanyl iontophoretic transdermal system), the first needle-free patient-activated analgesic system. IONSYS is indicated for the short-term management of acute postoperative pain in adult patients requiring opioid analgesia during hospitalization.
The IONSYS incorporates the
E-TRANS® iontophoretic transdermal drug delivery system developed by ALZA. E-TRANS utilizes iontophoresis to rapidly transport fentanyl across the skin and into the circulatory system of the body. IONSYS securely adheres to the upper outer arm or chest and provides patients an on-demand dose of fentanyl.
The system is "bi-cruciate stabilized," providing functions for
both the anterior and posterior cruciate ligaments.
IONSYS is indicated for the short-term management of acute postoperative pain in adult patients requiring opioid analgesia during hospitalization. Patients should be titrated to an acceptable level of analgesia before initiating treatment with IONSYS. IONSYS is not intended for home use. It is not recommended for patients under the age of 18 years.
When pain medication is needed, the patient double-clicks the dosing button, which delivers a pre-programmed, 40-mg dose of fentanyl through the skin. Each dose is delivered over a 10-minute period. Patients should be titrated to comfort before initiating IONSYS. IONSYS should be applied to intact, non-irritated and non-irradiated skin on the chest or upper outer arm. Patients must have access to supplemental analgesia.
IONSYS will be marketed in the United States by Ortho-McNeil, Inc., and in the European Union by Janssen-Cilag companies. Distribution of IONSYS is expected in 2007. For full prescribing information, including the boxed warning, contact the Ortho-McNeil Janssen Customer Communications Center (1-800-526-7736).
|
Subtle Cavus Orthotic
| dj Orthopedics, Inc. has announced the release of the DonJoy® ArchRival™, a patented, pre-fabricated foot orthotic for the treatment of subtle cavus foot.
DonJoy's ArchRival is constructed with a reduced medial arch and recessed area under the first metatarsal head to accommodate the plantar-flexed first ray. An incorporated elevated heel allows for shock absorption and accommodation of tight calf musculature, often seen with subtle cavus foot. In addition, each ArchRival is designed with X-Static Technology, silver-coated fibers woven into the surface layer of fabric to assist in the prevention of pathogens, blisters, and odors. The ArchRival is available in 7 sizes and is designed to fit in most types of athletic and walking shoes.
To learn more, contact
djorthopedics
2985 Scott Street
Vista CA 92801
Phone (800) 321-9549
fax (760) 734-3595
www.djortho.com
|
|
